Identifying pharmacogenetic risk factors for alkylating agent-related gonadotoxicity such as the presence of a CYP3A4*3 allele may improve risk prediction models for reduced ovarian function and consequent infertility in female CCSs. The gene discussed is CYP3A4; the disease is Infertility.